Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Ozempic
Ozempic
Biohaven hopes to muscle in on Ozempic with a different type of weight loss drug
Biohaven hopes to muscle in on Ozempic with a different type of weight loss drug
BioPharma Dive
Biohaven
weightloss
Ozempic
Wegovy
Flag link:
German regulator eyes Ozempic export ban amid shortages across Europe
German regulator eyes Ozempic export ban amid shortages across Europe
Reuters
Novo Nordisk
Ozempic
Europe
Germany
exporting
Flag link:
Senator floats new models to manage costs of weight loss drugs like Ozempic
Senator floats new models to manage costs of weight loss drugs like Ozempic
Stat
Novo Nordisk
Wegovy
Ozempic
weightloss
Senate
drug pricing
Flag link:
Novo Nordisk shrugs off supply issues with record sales
Novo Nordisk shrugs off supply issues with record sales
Pharmaphorum
Novo Nordisk
Ozempic
earnings
Flag link:
Demand for Ozempic and Wegovy Is Through the Roof. Here's Why it Can Go Even Higher.
Demand for Ozempic and Wegovy Is Through the Roof. Here's Why it Can Go Even Higher.
Motley Fool
Novo Nordisk
Ozempic
Wegovy
diabetes
weight loss
Flag link:
Belgium plans temporary ban on use of Ozempic for weight loss
Belgium plans temporary ban on use of Ozempic for weight loss
Yahoo/Reuters
Novo Nordisk
Ozempic
diabetes
weight loss
Belgium
drug shortages
Flag link:
High-flying Novo Nordisk once again dials up its 2023 sales and profit expectations
High-flying Novo Nordisk once again dials up its 2023 sales and profit expectations
Fierce Pharma
Novo Nordisk
Ozempic
Wegovy
Flag link:
Fresenius Medical: effect of drugs like Ozempic on patient numbers is neutral
Fresenius Medical: effect of drugs like Ozempic on patient numbers is neutral
Yahoo/Reuters
Fresenius Medical Care
Ozempic
diabetes
weight loss
Novo Nordisk
dialysis
Medtech
Flag link:
Far More Employers Could Cover Weight Loss Drugs Like Wegovy Next Year—Here’s What That Means For Costs
Far More Employers Could Cover Weight Loss Drugs Like Wegovy Next Year—Here’s What That Means For Costs
Forbes
weight loss
Ozempic
Wegovy
Novo Nordisk
Eli Lilly
Mounjaro
Flag link:
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
CP Wire/Businesswire
weight loss
patients
physicians
Sermo
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
Mounjaro
Flag link:
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
weight loss
patients
physicians
Sermo
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
Mounjaro
Flag link:
2 Reasons Why Eli Lilly's Mounjaro Might Beat Novo Nordisk's Ozempic, and 2 Reasons Why It Might Not
2 Reasons Why Eli Lilly's Mounjaro Might Beat Novo Nordisk's Ozempic, and 2 Reasons Why It Might Not
Motley Fool
Novo Nordisk
Eli Lilly
Ozempic
Mounjaro
diabetes
weight loss
Flag link:
GLP-1 Agonists, Like Ozempic and Wegovy, Have Risk of Gut Issues: Study
GLP-1 Agonists, Like Ozempic and Wegovy, Have Risk of Gut Issues: Study
BioSpace
Novo Nordisk
Ozempic
Wegovy
GLP-1 agonist
JAMA
Flag link:
At Viatris' request, US agency will review another Novo Nordisk patent on semaglutide
At Viatris' request, US agency will review another Novo Nordisk patent on semaglutide
Fierce Pharma
Viatris
generics
Novo Nordisk
Ozempic
Wegovy
diabetes
patents
USPTO
Flag link:
US Patent Office won't review two Novo Nordisk patents for Wegovy, Ozempic
US Patent Office won't review two Novo Nordisk patents for Wegovy, Ozempic
Yahoo/Reuters
patents
Novo Nordisk
generics
Wegovy
Ozempic
Flag link:
FDA Adds New Warning for Ileus to Ozempic Label
FDA Adds New Warning for Ileus to Ozempic Label
HCP Live
Novo Nordisk
Ozempic
diabetes
weight losss
FDA
ileus
labeling
Flag link:
Obesity Drug Market Set to Hit $100 Billion by 2035, BMO Says
Obesity Drug Market Set to Hit $100 Billion by 2035, BMO Says
Yahoo/Bloomberg
Novo Nordisk
Ozempic
Wegovy
obesity
weight loss
Flag link:
Why a hidden message in Ozempic’s logo represents a big shift in drug branding
Why a hidden message in Ozempic’s logo represents a big shift in drug branding
Fast Company
Novo Nordisk
Ozempic
logo
branding
diabetes
weight loss
Flag link:
After treatment with semaglutide, people with newly diagnosed type 1 diabetes needed little or no insulin
After treatment with semaglutide, people with newly diagnosed type 1 diabetes needed little or no insulin
Medical News Today
Novo Nordisk
Ozempic
semaglutide
type 1 diabetes
Flag link:
Novo Nordisk Is Already Working on Ozempic 2.0
Novo Nordisk Is Already Working on Ozempic 2.0
Motley Fool
Novo Nordisk
diabetes
obesity
weight loss
Ozempic
Wegovy
Flag link:
Pages
1
2
3
4
5
next ›
last »